Professor Honda (Nippon Medical School, Tokyo, Japan) and colleagues discovered the aberrant processing of the C-terminal ends of amino acids of circulating apolipoprotein A2 in the blood of patients with pancreatic cancer and individuals at high risk for pancreatic cancer. Toray Industries, Inc. (Tokyo, Japan) obtained approval for in vitro diagnostics (IVD) for the detection of pancreatic cancer from the Ministry of Health, Labour and Welfare of Japan through collaboration with Nippon Medical School and the National Cancer Center (Tokyo, Japan), and with support from the Japan Agency for Medical Research and Development.
Read the full article here (PDF：233KB).